Home/Pipeline/PG-002

PG-002

Cell Culture / TGFβ1 Inhibitor

CommercialLaunched

Key Facts

Indication
Cell Culture / TGFβ1 Inhibitor
Phase
Commercial
Status
Launched
Company

About PeptiGrowth

Develops synthetic peptide alternatives to growth factors for xeno-free cell culture in regenerative medicine.

View full company profile

Therapeutic Areas